A Clinical and Histopathologic Perspective on Evolving Noninvasive and Invasive Alternatives for Liver Biopsy

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 5, 2008, Pages 491-496

  Van Leeuwen, Dirk J ^a   Balabaud, Charles ^b   Crawford, James M ^c,d,e   Bioulac Sage, Paulette ^c,d,f   Dhillon, Amar P ^g  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HÔPITAL SAINT ANDRÉ   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f HÔPITAL PELLEGRIN   (France)

^g ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMORBIDITY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; INVASIVE PROCEDURE; LIVER BIOPSY; LIVER DISEASE; NON INVASIVE PROCEDURE; PROGNOSIS; SURGICAL RISK; TREATMENT OUTCOME;

EID: 42949144185     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.02.023     Document Type: Article

References (68)

1. C.A. Siegel A.M. Silas A.A. Suriawinata Liver biopsy 2005: when and how? Cleve Clin J Med 72 2005 199 201 206, 208 passim
2. H. Sheela S. Seela C. Caldwell Liver biopsy: evolving role in the new millennium J Clin Gastroenterol 39 2005 603 610
3. L.S. Friedman Controversies in liver biopsy: who, where, when, how, why? Curr Gastroenterol Rep 6 2004 30 36
4. B. Marek D. Kajdaniuk U. Mazurek TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy J Clin Pharm Ther 30 2005 271 277
5. D.C. Rockey D.M. Bissell Noninvasive measures of liver fibrosis Hepatology 43 2006 S113 S120
6. G.M. Dahab M.M. Kheriza H.M. El-Beltagi Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software J Gastroenterol Hepatol 19 2004 78 85
7. R. Morra M. Munteanu F. Imbert-Bismut FibroMAX: towards a new universal biomarker of liver disease? Expert Rev Mol Diagn 7 2007 481 490
8. M. Guido G. Colloredo M. Fassan Clinical practice and ideal liver biopsy sampling standards: not just a matter of centimeters J Hepatol 44 2006 823 824
9. M. Guido M. Rugge Liver biopsy sampling in chronic viral hepatitis Semin Liver Dis 24 2004 89 97
10. D.E. Kleiner The liver biopsy in chronic hepatitis C: a view from the other side of the microscope Semin Liver Dis 25 2005 52 64
11. V. Ratziu F. Charlotte A. Heurtier Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 2005 1898 1906
12. T.D. Schiano S. Azeem C.A. Bodian Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C Clin Gastroenterol Hepatol 3 2005 930 935
13. D.J. van Leeuwen The imager replacing the pathologist in the diagnosis of hepatobiliary and pancreatic disease Ann Diagn Pathol 5 2001 57 66
14. R.G. Gish A.C. Gadano Chronic hepatitis B: current epidemiology in the Americas and implications for management J Viral Hepat 13 2006 787 798
15. E.B. Keeffe D.T. Dieterich S.H. Han A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update Clin Gastroenterol Hepatol 4 2006 936 962
16. N.A. Terrault J.M. Pawlotsky J. McHutchison Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy J Viral Hepat 12 2005 465 472
17. J.M. Pawlotsky Current and future concepts in hepatitis C therapy Semin Liver Dis 25 2005 72 83
18. J. Massard V. Ratziu D. Thabut Natural history and predictors of disease severity in chronic hepatitis C J Hepatol 44 2006 S19 S24
19. G. Reiss E.B. Keeffe Role of liver biopsy in the management of chronic liver disease: selective rather than routine Rev Gastroenterol Disord 5 2005 195 205
20. L. Sandrin B. Fourquet J.M. Hasquenoph Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
21. L. Sandrin M. Tanter J.L. Gennisson Shear elasticity probe for soft tissues with 1-D transient elastography IEEE Trans Ultrason Ferroelectr Freq Control 49 2002 436 446
22. T. Poynard V. Ratziu S. Naveau The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis Comp Hepatol 4 2005 10
23. P.J. Thuluvath K.L. Krok Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol 100 2005 1981 1983
24. A.K. Burroughs E. Cholongitas Non-invasive tests for liver fibrosis: encouraging or discouraging results? J Hepatol 46 2007 751 755
25. G. Sebastiani A. Alberti Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy World J Gastroenterol 12 2006 3682 3694
26. G. Sebastiani A. Vario M. Guido Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B World J Gastroenterol 13 2007 525 531
27. R. Malik N. Afdhal Stiffness and impedance: the new liver biomarkers Clin Gastroenterol Hepatol 5 2007 1144 1146
28. P. Bedossa D. Dargere V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
29. V.J. Desmet Comments on cirrhosis reversal Dig Liver Dis 37 2005 909 916
30. V.J. Desmet T. Roskams Cirrhosis reversal: a duel between dogma and myth J Hepatol 40 2004 860 867
31. K. Patel D.R. Nelson D.C. Rockey Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C Clin Gastroenterol Hepatol 6 2008 242 247
32. V. Leroy M.N. Hilleret N. Sturm Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C J Hepatol 46 2007 775 782
33. J.M. Crawford Evidence-based interpretation of liver biopsies Lab Invest 86 2006 326 334
34. M. Kurosaki N. Izumi External validation of FIB-4: diagnostic accuracy is limited in elderly populations Hepatology 47 2008 352
35. G. Sebastiani A. Vario M. Guido Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases J Viral Hepat 15 2008 212 218
36. B. Coco F. Oliveri A.M. Maina Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases J Viral Hepat 14 2007 360 369
37. G. Leandro A. Mangia J. Hui Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
38. C. Aube B. Winkfield F. Oberti New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis Eur J Gastroenterol Hepatol 16 2004 743 751
39. A.K. Lim N. Patel R.J. Eckersley Can Doppler sonography grade the severity of hepatitis C-related liver disease? AJR Am J Roentgenol 184 2005 1848 1853
40. A.K. Lim S.D. Taylor-Robinson N. Patel Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C Gut 54 2005 128 133
41. M.J. Blomley A.K. Lim C.J. Harvey Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study Gut 52 2003 1188 1193
42. M. Lewin A. Poujol-Robert P.Y. Boelle Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C Hepatology 46 2007 658 665
43. O. Rouviere M. Yin M.A. Dresner MR elastography of the liver: preliminary results Radiology 240 2006 440 448
44. D.A. Aguirre C.A. Behling E. Alpert Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging Radiology 239 2006 425 437
45. H. Nyblom E. Bjornsson M. Simren The AST/ALT ratio as an indicator of cirrhosis in patients with PBC Liver Int 26 2006 840 845
46. H. Nyblom U. Berggren J. Balldin High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking Alcohol Alcohol 39 2004 336 339
47. E. Giannini F. Botta A. Fasoli Progressive liver functional impairment is associated with an increase in AST/ALT ratio Dig Dis Sci 44 1999 1249 1253
48. J.A. Cohen M.M. Kaplan The SGOT/SGPT ratio—an indicator of alcoholic liver disease Dig Dis Sci 24 1979 835 838
49. D.M. Lebensztejn E. Skiba M. Sobaniec-Lotowska A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B Hepatology 41 2005 1434 1435
50. C.T. Wai J.K. Greenson R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
51. C. Ripoll R. Groszmann G. Garcia-Tsao Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis Gastroenterology 133 2007 481 488
52. S. Nagula D. Jain R.J. Groszmann Histological-hemodynamic correlation in cirrhosis—a histological classification of the severity of cirrhosis J Hepatol 44 2006 111 117
53. A. Blasco X. Forns J.A. Carrion Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation Hepatology 43 2006 492 499
54. D.J. van Leeuwen S. Sherlock P.J. Scheuer Wedged hepatic venous pressure recording and venography for the assessment of pre-cirrhotic and cirrhotic liver disease Scand J Gastroenterol 24 1989 65 73
55. T. Poynard V. Ratziu Y. Benhamou Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy? Gastroenterology 128 2005 1146 1148
56. C. Colletta C. Smirne C. Fabris Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases Hepatology 42 2005 838 845
57. L. Castera J. Vergniol J. Foucher Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
58. P. Cales F. Oberti S. Michalak A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 42 2005 1373 1381
59. N.H. Afdhal Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem 50 2004 1299 1300
60. R.J. Chalmers B. Kirby A. Smith Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis Br J Dermatol 152 2005 444 450
61. X. Forns S. Ampurdanes J.M. Llovet Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992
62. M. Fraquelli C. Rigamonti G. Casazza Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease Gut 56 2007 968 973
63. J. Foucher E. Chanteloup J. Vergniol Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study Gut 55 2006 403 408
64. V.C.L. De Ledinghen J. Foucher R. Tournan Evaluation of fibrosis regression using fibroscan in HCV responder patients A prospective controlled study (abstr) J Hepatol 564 2006 S210
65. J.A. Carrion M. Navasa J. Bosch Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation Liver Transpl 12 2006 1791 1798
66. V.L.B.B. De Ledinghen L. Rebouissoux J. Foucher Fibroscan® is a new non-invasive method for the diagnosis of liver fibrosis in children: a prospective comparison with Fibrosure and liver biopsy (abstr) Hepatology 42 2005 473A
67. V.C.L. de Ledinghen J. Foucher P.H. Bernard Repeated liver stiffness measurement using Fibroscan for the follow-up of untreated HCV patients and for the evaluation and monitoring of histological response in HCV responders—a prospective longitudinal study (abstr) Hepatology 42 2005 656A
68. C.M.F. Barrault C. Atanasiu C. Douvin Non invasive assessment of liver graft fibrosis by transient elastography after liver transplantation (abstr) Hepatology 42 Suppl 1 2005 485A